Business Context and Reporting Period
This Form 8-K reports on the 2024 Annual General Meeting of Shareholders held by InMed Pharmaceuticals Inc. on December 18, 2024. The company is incorporated in British Columbia and trades on The Nasdaq Stock Market LLC under the symbol "INM". The filing details the outcomes of shareholder votes regarding director elections and the appointment of an independent auditor.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on corporate governance events and voting results.
Material Changes and Voting Results
Proposal No. 1: Election of Directors
Shareholders voted on five director nominees. Four nominees were elected, while one nominee failed to receive a majority of votes cast.
- Elected Directors: Eric A. Adams (96.67% for), Andrew Hull (96.69% for), Bryan Baldasare (96.66% for), and Nicole Lemerond (96.67% for).
- Withheld Vote: Ms. Janet Grove received only 44.26% of votes cast, with 55.74% withheld. Consequently, Ms. Grove has tendered her resignation in accordance with the company's Majority Voting Policy. The Board's Nominating & Governance Committee will determine whether to accept the resignation.
Note: Vote counts reflect pre-split share amounts prior to the 1-for-20 reverse stock split completed in November 2024.
Proposal No. 2: Appointment of Auditor
Shareholders approved the appointment of Marcum LLP (now operating as CBIZ LLP) as the independent registered public accounting firm for the upcoming term. The proposal received 93.706% of votes in favor, with no votes against.
Guidance, Outlook, and Risks
The filing does not provide financial guidance, operational outlook, or specific risk factors. The primary contingency noted is the pending determination by the Board regarding the acceptance of Ms. Janet Grove's resignation. The company indicated that a further update will be provided following the Nominating & Governance Committee's assessment.
Investor Verification Checklist
- Verify the final status of Ms. Janet Grove's resignation and the Board's decision to accept or reject it.
- Confirm the composition of the Board of Directors following the 2024 Annual General Meeting.
- Review the press release (Exhibit 99.1) referenced in Item 7.01 for additional context on the meeting.
- Check subsequent filings for the company's financial status, as this 8-K contains no financial metrics.